Angelo Borsarelli Carvalho Brito

Learn More
Angiogenesis has been highlighted as a critical component in the progression of multiple myeloma (MM), and vascular endothelial growth factor (VEGF) as well as its type 2 receptor (VEGFR2) are thought to play a major role in the process. Single nucleotide polymorphisms (SNPs) have been described in VEGF and VEGFR2 genes, with quantitative or qualitative(More)
Diffuse large B-cell lymphoma (DLBCL) presented as a primary dural lesion is an extremely rare entity, which may be misdiagnosed as meningioma. Patients with symptomatic meningioma are usually treated with tumor resection. The five previously described cases of intracranial dural DLBCL were treated with surgery followed by chemotherapy and/or radiotherapy,(More)
MIMO systems promise high performance gains over conventional single antenna systems. To accomplish high data rates over wireless links the use of multiple transmit and receive antennas is an alternative that does not require any extra bandwidth. It has the potential to address the unprecedented demand for wireless services, particularly for the multimedia(More)
AIM Since VEGF polymorphisms were associated with variable protein production, we analyzed herein their roles in outcome of epithelial ovarian cancer (EOC) patients. METHODS Genotypes of 85 patients with primary EOC were identified in DNA by real-time PCR. Progression-free survival and overall survival were analyzed using Kaplan-Meier method, univariate(More)
Angiogenesis (AG) based on immunohistochemistry (IHC) for related proteins is a rather contradictory prognostic marker in follicular lymphoma (FL). 1,2 These inconsistencies may result from the variety of treatments in different cohorts, and also from the complex tumor–host interaction in this disease. 3 The vascular endothelial growth factor A (VEGFA),(More)
This study aimed to evaluate whether GSTM1 and GSTT1 (presents or nulls), GSTP1 c.313A>G and NQO2 c.-102A>C polymorphisms, involved in xenobiotic detoxification pathways, alter outcomes of epithelial ovarian cancer (EOC) patients. DNA from 84 EOC patients diagnosed at the University of Campinas Academic Hospital from January 1995 and July 2007 was analyzed(More)